33 results
S-3ASR
EX-1.2
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
30 Sep 22
Automatic shelf registration
4:17pm
and contractual obligations relating to the privacy and security of IT Systems and Personal Data (“Data Protection Laws”) and to the protection
425
icytej83yukn6n w000
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.2
d5nl uiiqzs2cla
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
b2hdfn
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
1hkwzlbew5qh hn
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-10.2
tbsq99 d0
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
gye5sydm
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-T
EX-99
tgb8g8 589
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
l6uu9ylv45
31 Aug 20
Third party tender offer statement
8:46am
SC TO-C
EX-2.1
cox72
10 Aug 20
Information about tender offer
9:50pm
8-K
EX-2.1
ryi11 aoic2b
10 Aug 20
Tender and Support Agreement
9:48pm